Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo
暂无分享,去创建一个
[1] J. Molkentin,et al. Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.
[2] Satoko Nishimoto,et al. MAPK signalling: ERK5 versus ERK1/2 , 2006, EMBO reports.
[3] Bo Zhou,et al. Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[4] R. Schwartz,et al. Cardiac-Specific Deletion of Gata4 Reveals Its Requirement for Hypertrophy, Compensation, and Myocyte Viability , 2006, Circulation research.
[5] M. Baccarini. Second nature: Biological functions of the Raf‐1 “kinase” , 2005, FEBS letters.
[6] Anthony J. Muslin,et al. Raf-1 Kinase Is Required for Cardiac Hypertrophy and Cardiomyocyte Survival in Response to Pressure Overload , 2004, Circulation.
[7] Ming-Ming Zhou,et al. Structure and regulation of MAPK phosphatases. , 2004, Cellular signalling.
[8] P. Doevendans,et al. MEK1-ERK2 Signaling Pathway Protects Myocardium From Ischemic Injury In Vivo , 2004, Circulation.
[9] Jian Xu,et al. Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac Hypertrophy , 2004, Circulation research.
[10] S. Meloche,et al. An essential function of the mitogen‐activated protein kinase Erk2 in mouse trophoblast development , 2003, EMBO reports.
[11] Bo Zhou,et al. A Bipartite Mechanism for ERK2 Recognition by Its Cognate Regulators and Substrates* , 2003, Journal of Biological Chemistry.
[12] Q. Liang,et al. Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter , 2003, Circulation research.
[13] J. Molkentin,et al. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. , 2002, Circulation research.
[14] W. Kolch,et al. Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. , 2002, Journal of cell science.
[15] Yu Zhao,et al. The Mechanism of Dephosphorylation of Extracellular Signal-regulated Kinase 2 by Mitogen-activated Protein Kinase Phosphatase 3* , 2001, The Journal of Biological Chemistry.
[16] B. Harrison,et al. Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. , 2001, Journal of applied physiology.
[17] D. Lawrence,et al. Multiple Regions of MAP Kinase Phosphatase 3 Are Involved in Its Recognition and Activation by ERK2* , 2001, The Journal of Biological Chemistry.
[18] R. Kitsis,et al. The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice , 2000, The EMBO journal.
[19] J. Denu,et al. Mechanistic Basis for Catalytic Activation of Mitogen-activated Protein Kinase Phosphatase 3 by Extracellular Signal-regulated Kinase* , 2000, The Journal of Biological Chemistry.
[20] J. Molkentin,et al. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] J. Pouysségur,et al. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. , 1999, Science.
[22] H. Hotta,et al. Requirement of activation of the extracellular signal-regulated kinase cascade in myocardial cell hypertrophy. , 1999, Journal of molecular and cellular cardiology.
[23] G L Johnson,et al. Organization and regulation of mitogen-activated protein kinase signaling pathways. , 1999, Current opinion in cell biology.
[24] A. Clerk,et al. Stimulation of the p38 Mitogen-activated Protein Kinase Pathway in Neonatal Rat Ventricular Myocytes by the G Protein–coupled Receptor Agonists, Endothelin-1 and Phenylephrine: A Role in Cardiac Myocyte Hypertrophy? , 1998, The Journal of cell biology.
[25] P. Sugden,et al. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. , 1996, Circulation research.
[26] M. Cobb,et al. ERK3 Is a Constitutively Nuclear Protein Kinase (*) , 1996, The Journal of Biological Chemistry.
[27] A. Thorburn,et al. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. , 1994, The Journal of biological chemistry.
[28] J. Frost,et al. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy , 1994, The Journal of cell biology.
[29] D. Levy,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.